Clinical Trials

Biohaven Pharmaceuticals asserted that it has enrolled the first patient in a Phase 3 Clinical Trial of Zydis that is a orally dissolving tablet formulation of rimegepant for the…
Read More...

Contego Medical has affirmed the enrollment in the PERFORMANCE I Trial, a clinical trial designed to evaluate the safety and feasibility of the Neuroguard IEP 3-in-1 Carotid Stent and…
Read More...

GlycoMimetics unveiled design for a randomized, double blind, placebo-controlled Phase 3 Clinical Trial to evaluate GMI-1271 in combination with MEC (Mitoxantrone, etoposide and Ara-C)…
Read More...

Biopharmaceutical company, Moleac that is focused on research and development of new medicines for central nervous system (CNS) diseases and injuries, today announced that the U.S. Food…
Read More...

Benitec Biopharma which is a biotechnology company developing innovative therapeutics based on a combination of gene therapy and its patented gene-silencing technology named ddRNAi…
Read More...

Trovagene which is a precision medicine biotechnology company developing targeted cancer therapeutics asserted that the initial patient successfully completed first cycle 1 Treatment in…
Read More...

Lyric Pharmaceuticals which is a biopharmaceutical company asserted the completion of enlisting for PROMOTE Study which is an international multi-center, randomized, controlled Phase 2…
Read More...

Aimmune Therapeutics which is a bio pharmaceutical company curating treatments for fatal food allergies, announced that the results of its pivotal Phase 3 PALISADE trial of AR101 for…
Read More...

Biogen and Abbvie asserted voluntary worldwide withdrawal of ZINBRYTA for relapsing multiple sclerosis. Taking into account the limited number of patients who are being treated,…
Read More...

JHL Biotech has asserted that the Dutch Healthcare Authority has sanctioned a Clinical Trial Application for JHL's dornase alfa biosimilar, JHL1922 to enhance pulmonary function of…
Read More...

Jazz Pharmaceuticals affirmed that the U.S Food and Drug Administration has conceded for filing with standard review the company's New Drug Application requesting marketing approval for…
Read More...

BioAtla which is a global biotechnology company aiming to develop Conditionally Active Biologic protein Therapeutics announced the treatment of first patient in its clinical trial…
Read More...

Sangamo Therapeutics declared that the Medicines and Healthcare Products Regulatory Agency of the United Kingdom has extended Clinical Trial Authorization for enlisting subjects into…
Read More...

MabVax Therapeutics , a clinical-stage biotechnology company that aims to develop antibody-based products to address unattainable medical needs to treat cancer declared positive results…
Read More...

Median Technologies, the industry-leading Imaging Phenomics Company and CMIC HOLDINGS Co., Ltd. (CMIC), a leading Contract Research Organization (CRO) with services for development,…
Read More...

ENYO Pharma SA declared that it is strengthening its leadership team with the appointment of a VP Non-Clinical Development & Product Profiling. ENYO Pharma also confirms that its…
Read More...

Celltex Therapeutics Corporation asserted its authorization to conduct an investigational protocol which is a Phase II B Wellness Protocol Clinical Study on Rheumatoid Arthritis and…
Read More...

Abbott and Surmodics proclaimed having forayed into an agreement wherein Abbott will possess exclusive commercialization rights for Surmodic's Surveil drug-coated balloon to treat the…
Read More...

Longeveron asserted that its revolutionary Clinical Trial initiated to treat infants with Hypoplastic Left Heart Syndrome as the first patient received the treatment using the company's…
Read More...

Eli Lilly and Company proclaimed that the USFood and Drug Administration has sanctioned Verzenio (abemaciclib) in combination with an aromatase inhibitor (AI) as initial endocrine-based…
Read More...